Company news
Jenburkt Pharmaceuticals Ltd news in 2026
Jenburkt Pharmaceuticals Ltd's news releases, calls and decks from 2026, newest first.
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
November 4, 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
November 4, 2026
Board Meeting Intimation for Considering And Approving Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September, 2026.
October 29, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
October 12, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
October 12, 2026
Jenburkt Pharmaceuticals Ltd Press Release Sep 04 2026
September 4, 2026
Jenburkt Pharmaceuticals Ltd Press Release Aug 07 2026
August 7, 2026
Jenburkt Pharmaceuticals Ltd Press Release Aug 04 2026
August 4, 2026
Jenburkt Pharmaceuticals Ltd Press Release Aug 03 2026
August 3, 2026
Jenburkt Pharmaceuticals Ltd Press Release Jul 29 2026
July 29, 2026
Jenburkt Pharmaceuticals Ltd Press Release Jul 13 2026
July 13, 2026
Jenburkt Pharmaceuticals Ltd Press Release Jun 18 2026
June 18, 2026
Jenburkt Pharmaceuticals Ltd Press Release May 27 2026
May 27, 2026
Jenburkt Pharmaceuticals Ltd Press Release May 06 2026
May 6, 2026
Jenburkt Pharmaceuticals Ltd Press Release Apr 28 2026
April 28, 2026
Jenburkt Pharmaceuticals Ltd Press Release Apr 07 2026
April 7, 2026
Jenburkt Pharmaceuticals Ltd Press Release Mar 23 2026
March 23, 2026
Jenburkt Pharmaceuticals Ltd Press Release Feb 04 2026
February 4, 2026
Jenburkt Pharmaceuticals Ltd Press Release Feb 03 2026
February 3, 2026
Jenburkt Pharmaceuticals Ltd Press Release Jan 28 2026
January 28, 2026
Jenburkt Pharmaceuticals Ltd Press Release Jan 07 2026
January 7, 2026